Elizabeth Osborne Buschur, MD

University of Michigan
Internal Medicine, Division of Endocrinology
A Novel CYP17A1 Mutation in a Compound Heterozygote and Response to Mineralocorticoid Receptor Antagonist Therapy
LB-OR-1 Marked Androgen Reduction in Adult Women With Classic 21-Hydroxylase Deficiency (21OHD) Treated With Abiraterone Acetate (AA) Added to Physiologic Hydrocortisone (HC) and Fludrocortisone (FC)